Nayimoglu, MehmetSarıfakıo?lu, Ayşe BanuUstaömer, KübraAkgül, MuratArslan, Ayşegül2022-05-112022-05-1120212587-1250https://doi.org/10.5606/tftrd.2021.5135https://hdl.handle.net/20.500.11776/5248Infliximab is an inhibitory of tumor necrosis factor-alpha which is used successfully for the treatment of inflammatory bowel disease and rheumatic disease. It has various side effects including injection-induced reactions, immunosuppression, demyelinating diseases, and cardiac effects. One of the most serious side effects is tuberculosis. In particular, the immunosuppressant drugs have a high risk of reactivating latent tuberculosis infection. Its activation probably may occur as an extra-pulmonary and, occasionally, may result in an unusual infection. Herein, we report a 30-year-old male case treated with infliximab and suffered from isolated testicular tuberculosis.en10.5606/tftrd.2021.5135info:eu-repo/semantics/openAccessInfliximabtesticular tuberculosistumor necrosis factor-alphaTumor-Necrosis-FactorOrchitisArticle673374377Q4WOS:00069219700001651722734870127